Poster Presentation: 2011
In 2011 OMNI Health Care built upon the outstanding results of our osteoporosis strategy/falls prevention program by implementing phase two of the initiative – a policy to ensure appropriate pharmacotherapy for all residents. Last year, we developed an osteoporosis Continue Reading
Amgen Canada is pleased to announce that PROLIA (denosumab) is now on the Ontario Formulary – LU Code 428 or 429 and is covered by most private payers.
Download Announcement Details
Website Resource
Health Canada posts safety alerts, Public Health Advisories, Warnings, Recalls, press releases and other notices from industry on marketed health products, including Natural Health Products and medical devices.
Research Study Abstract: 2011
L. A. Beaupre & S. R. Majumdar & S. Dieleman & A. Au & D. W. Morrish
2011 Osteoporos Int DOI 10.1007/s00198-011-1582-5
Abstract
Summary: Bisphosphonate treatment rates were examined before and after admission to long-term residential care. Continue Reading
Recommended reading list for Osteoporosis Treatment and Management.
Download Reading List
Reading lists are compiled by Tara Harvie, an Information Specialist at SHRTN (Seniors Health Research Transfer Network). Thank you Tara for providing this helpful resource.
For copies of articles on this list, please call 905.521.2100 ext. 12476 or email harvie@hhsc.ca
